Valero Energy Corporation vs Bristol-Myers Squibb Company
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Valero Energy Corporation
$120.7B
μμ #134
Bristol-Myers Squibb Company
$125.6B
μμ #132
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ°λλ³ λΉκ΅
| μ°λ | Valero Energy Corporation | Bristol-Myers Squibb Company | μ λ |
|---|---|---|---|
| 2026 | $120.7B | $125.6B | Bristol-Myers Squibb Company |
| 2025 | $47.8B | $107.8B | Bristol-Myers Squibb Company |
| 2024 | $34.9B | $107.6B | Bristol-Myers Squibb Company |
| 2023 | $36.0B | $92.9B | Bristol-Myers Squibb Company |
| 2022 | $34.0B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $19.4B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $13.8B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $21.5B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $16.5B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $19.6B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $14.0B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $13.9B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $9.5B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $9.5B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $5.7B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $3.5B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $3.7B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $2.7B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $3.4B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $10.7B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $7.8B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $7.8B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $3.4B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $1.7B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $1.4B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $1.4B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $1.3B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $709.4M | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $746.5M | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $1.1B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $667.3M | $18.8B | Bristol-Myers Squibb Company |
| 1995 | $559.0M | $14.3B | Bristol-Myers Squibb Company |
| 1994 | $375.7M | $9.2B | Bristol-Myers Squibb Company |